Address
Novo A/S
19 Tuborg Havnevej
2900 Hellerup
Denmark
Website
Recent investment activity
KANDO id: 30981
Relation
Renamed to
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 28| Company | Profile | Country | Date Sort descending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
MediQuest Therapeutics Inc | A specialty pharmaceutical company developing topical therapies to treat patients suffering from inflammatory and infectious diseases. | N/A | |||
|
|
Gloucester Pharmaceuticals Inc | N/A | ||||
|
Inogen Inc | Developer and manufacturer of homecare products and services for oxygen therapy patients. | N/A | |||
|
|
Amira Pharmaceuticals Inc | A small molecule pharmaceutical company focused on the discovery and early development of compounds. | N/A | |||
|
|
Panmira Pharmaceuticals LLC | Pharmaceutical company for inflammatory diseases. | N/A | |||
|
|
Logical Therapeutics Inc | An early stage biotechnology company | N/A | |||
|
|
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | |||
|
|
Amira Pharmaceuticals Inc | A small molecule pharmaceutical company focused on the discovery and early development of compounds. | N/A | |||
|
|
Ophthotech Corp | Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. | N/A | |||
|
|
Lux Biosciences Inc | Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. | N/A | |||
|
|
PTC Therapeutics Inc | Biopharmaceutical company. | N/A | |||
|
|
NeuroTherapeutics Pharma Inc | N/A | ||||
|
|
Imagen Biotech Inc | N/A | ||||
|
|
Asante Solutions Inc | Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. | N/A | |||
|
|
Synosia Therapeutics | Develops innovative treatments for disorders of the central nervous system | N/A | |||
|
|
Light Sciences Oncology Inc | Drug-device cancer therapy | Series A | |||
|
|
Symphogen | Series D | ||||
|
|
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | |||
|
|
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series C | |||
|
|
Tobira Therapeutics Inc | Dedicated to the clinical development of antiviral products | Series B | |||
|
|
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series F | |||
|
|
Symphogen | Series F | ||||
|
|
Orphazyme ApS | Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases. | Seed | |||
|
|
High Throughput Genomics Inc | Series D | ||||
|
|
Delenex Therapeutics AG | Series A |